“Our partnership with Verenium will allow us to work together to develop and commercialize a suite of new enzyme products for the global animal nutrition and health market,” notes Thad Simons, president and chief executive officer of Novus International.

Combining the strengths of two industry leaders builds on Novus' existing enzyme offering and knowledge of animal nutrition by offering the strength of Verenium’s world class enzyme biotechnology. 

—From Novus International news release